Amanda Abramovich

Title: Amanda Abramovich: Innovator in Insulin Delivery Technology

Introduction

Amanda Abramovich is a notable inventor based in Arlington, MA (US). She has made significant contributions to the field of insulin delivery technology, holding 2 patents that enhance the management of diabetes. Her work focuses on improving the accuracy and efficiency of insulin delivery systems.

Latest Patents

Amanda's latest patents include a groundbreaking system and method for calculating insulin on board (IOB) for an extended bolus being delivered by an insulin infusion pump. This innovative approach calculates an extended bolus IOB value, taking into account the insulin currently on board from the extended bolus and the insulin scheduled to be delivered over a subsequent time period equivalent to the duration of insulin action. The extended bolus IOB value can be utilized to calculate a suggested bolus, thereby optimizing insulin management for users.

Career Highlights

Amanda is currently employed at Insulet Corporation, where she continues to develop advanced solutions for insulin delivery. Her expertise and dedication to innovation have positioned her as a key player in the field of diabetes management technology.

Collaborations

Amanda collaborates with various professionals in her field, including her coworker Robert W Campbell, to drive forward the development of effective insulin delivery systems.

Conclusion

Amanda Abramovich's contributions to insulin delivery technology exemplify her commitment to improving the lives of individuals with diabetes. Her innovative patents and collaborative efforts at Insulet Corporation highlight her role as a leading inventor in this critical area of healthcare.